Chargement en cours...
Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro
CHK1 is an important regulator of the cell cycle and DNA damage response, and its altered expression has been identified in various tumors. Chk1 inhibitors are currently being evaluated as monotherapy and as potentiators of chemotherapy in clinical settings. However, to our knowledge, no previous st...
Enregistré dans:
| Publié dans: | Cancer Med |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6089182/ https://ncbi.nlm.nih.gov/pubmed/29963769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1638 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|